title: Acneiform eruption following anti-TNF-alpha treatment: a report of three cases.
abstract: Tumor necrosis factor-alpha (TNF-alpha) antagonists are used to treat many autoimmune disorders including Crohn's disease, ulcerative colitis, rheumatoid arthritis, and more recently, psoriasis. The adverse effects of the treatment regimen for psoriasis are not as well documented as those for Crohn's disease and rheumatoid arthritis. We report the development of acne vulgaris in 3 patients with psoriasis after initiating anti-TNF-alpha therapy.
authors.affiliation: Department of Dermatology, Baylor College of Medicine, Houston, TX 77030, USA.
authors.forename: Grace
authors.initials: G
authors.lastname: Sun
authors.forename: Carina A
authors.initials: CA
authors.lastname: Wasko
authors.forename: Sylvia
authors.initials: S
authors.lastname: Hsu
mesh_terms: D017486:Acneiform Eruptions / Q000139:chemically induced*; D000068879:Adalimumab; D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D005260:Female; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068879:Adalimumab